Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06266481Phase 3Recruiting
Phase 3, randomised trial of dexamethasone iontophoretic patch in postoperative sore throat (POST) (2 arms), sponsored by Pharos University in Alexandria. Primary endpoint: Post-operative Sore Throat Severity at 6 hours. Started Mar 2024; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06266481.